ResearcherSun Yat-sen UniversityActive in the last 2 years

Tai-Jun Yi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-0483-3757; OpenAlex author ID A5108907920. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

USP10 promotes cell proliferation and gemcitabine resistance in pancreatic cancer by the regulation of IGF2BP3-STEAP3. Co-author DOI 10.1038/s41388-025-03654-z ↗
The triglyceride-glucose index associated with reduced risk of liver metastasis in pancreatic cancer. Co-author DOI 10.3389/fendo.2025.1592788 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Guolin Li · 2 shared papers, 2025–2026 · strength 0.52
- Paper USP10 promotes cell proliferation and gemcitabine resistance in pancreatic cancer by the regulation of IGF2BP3-STEAP3. DOI 10.1038/s41388-025-03654-z ↗
- Paper The triglyceride-glucose index associated with reduced risk of liver metastasis in pancreatic cancer. DOI 10.3389/fendo.2025.1592788 ↗
Yong-Ling Liang · 1 shared paper, 2026 · strength 0.28
- Paper USP10 promotes cell proliferation and gemcitabine resistance in pancreatic cancer by the regulation of IGF2BP3-STEAP3. DOI 10.1038/s41388-025-03654-z ↗
Xingyu Li · 1 shared paper, 2025 · strength 0.24
- Paper The triglyceride-glucose index associated with reduced risk of liver metastasis in pancreatic cancer. DOI 10.3389/fendo.2025.1592788 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.